Effects of adherence to pharmacological secondary prevention after acute myocardial infarction on health care costs - an analysis of real-world data
Abstract Background Acute myocardial infarction (AMI), a major source of morbidity and mortality, is also associated with excess costs. Findings from previous studies were divergent regarding the effect on health care expenditure of adherence to guideline-recommended medication. However, gender-spec...
Saved in:
Main Authors: | Florian Kirsch (Author), Christian Becker (Author), Christoph Kurz (Author), Lars Schwettmann (Author), Anja Schramm (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Do sex and gender aspects influence non-adherence to secondary prevention measures after myocardial infarction?
by: Guillermo Moreno, et al.
Published: (2024) -
Cost-Effectiveness of Alirocumab for the Secondary Prevention of Cardiovascular Events after Myocardial Infarction in the Chinese Setting
by: Zhe Liang, et al.
Published: (2021) -
Using real world evidence to generate cost-effectiveness analysis of fibrinolytic therapy in patients with ST-segment elevation myocardial infarction in Thailand
by: Krittimeth Trerayapiwat, et al.
Published: (2022) -
Cost-effectiveness and cost-utility analysis of the use of clopidogrel and pantoprazole in comparison with clopidogrel and omeprazole for the secondary prevention of myocardial infarction in Iran
by: Mohammadreza Amirsadri, et al.
Published: (2021) -
Pharmacological Treatment of Tachyarrhythmias in Acute Myocardial Infarction - a Review
by: Alexandru DEACONU, et al.
Published: (2021)